Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Gastroenterology & Hepatology|December 13, 2017
Microscopic Colitis: A Review of Collagenous and Lymphocytic ColitisKaren Boland, Geoffrey C Nguyen
World Journal of Gastroenterology|March 23, 2022
"Role of exercise in preventing and restoring gut dysbiosis in patients with inflammatory bowel disease": A letter to the editorNeasa Mc Gettigan, Aoibhlinn O'Toole, Karen Boland
Clinical Nutrition ESPEN|December 13, 2022
Starving for knowledge. Addressing the place of clinical nutrition within undergraduate and postgraduate clinical training: A national survey of practicing cliniciansKaren Boland, Kathryn Allen, Adam James, et al.
International Journal of Colorectal Disease|June 9, 2021
Visceral adiposity and inflammatory bowel diseaseCatherine R Rowan, John McManus, Karen Boland, et al.
Journal of Crohn'S & Colitis|January 3, 2018
The Unfinished Symphony: Golimumab Therapy for Anti-Tumour Necrosis Factor Refractory Crohn's DiseaseTomer Greener, Karen Boland, A Hillary Steinhart, et al.
International Journal of Colorectal Disease|May 25, 2023
A systematic review of the effect of structured exercise on inflammation and body composition in inflammatory bowel diseaseNeasa Mc Gettigan, Kathryn Allen, Reza Saeidi, et al.
European Journal of Gastroenterology & Hepatology|March 18, 2021
Ustekinumab induction concentrations are associated with clinical and biochemical outcomes at week 12 of treatment in Crohn's diseaseMargaret Walshe, Krzysztof Borowski, Karen Boland, et al.
Clinical and Translational Gastroenterology|May 23, 2019
Mucosa-Associated Microbiota in Ileoanal Pouches May Contribute to Clinical Symptoms, Particularly Stool Frequency, Independent of Endoscopic Disease ActivityWilliams Turpin, Orlaith Kelly, Krzysztof Borowski, et al.
European Journal of Gastroenterology & Hepatology|August 17, 2021
Higher adalimumab maintenance regimen is more effective than standard dose in anti-TNF experienced Crohn's disease patientsTomer Greener, Karen Boland, Raquel Milgrom, et al.
International Journal of Colorectal Disease|January 30, 2021
The optimal management of anti-drug antibodies to infliximab and identification of anti-drug antibody values for clinical outcomes in patients with inflammatory bowel diseaseNeasa Mc Gettigan, Aman Shah Afridi, Grace Harkin, et al.
Pageof 2